Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1 and day 10
Awards & highlights
No Placebo-Only Group
Summary
This trial tests two skin creams on healthy adults to see if they are safe and how they are absorbed by the body.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 1 and day 10
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 and day 10
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
AEs following multiple ascending dose (MAD)
Incidence and severity of application site Adverse Events (AEs) as assessed by Draize score.
Incidence of laboratory abnormalities
+1 moreSecondary study objectives
Apparent Oral Clearance (CL/F)
Apparent Volume of Distribution (Vz/F)
Area Under the Curve From Time Zero to End of Dosing Interval (AUCτau)
+7 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: PF-07295324Experimental Treatment1 Intervention
Ointment
Group II: PF-07259955Experimental Treatment1 Intervention
Cream
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PF-07295324
2022
Completed Phase 1
~30
PF-07259955
2022
Completed Phase 1
~30
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
PfizerLead Sponsor
4,649 Previous Clinical Trials
17,744,352 Total Patients Enrolled
Pfizer CT.gov Call CenterStudy DirectorPfizer
3,536 Previous Clinical Trials
14,915,540 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger